Literature DB >> 28096243

Fused in Sarcoma Neuropathology in Neurodegenerative Disease.

Ian R A Mackenzie1, Manuela Neumann2.   

Abstract

Abnormal intracellular accumulation of the fused in sarcoma (FUS) protein is the characteristic pathological feature of cases of familial amyotrophic lateral sclerosis (ALS) caused by FUS mutations (ALS-FUS) and several uncommon disorders that may present with sporadic frontotemporal dementia (FTLD-FUS). Although these findings provide further support for the concept that ALS and FTD are closely related clinical syndromes with an overlapping molecular basis, important differences in the pathological features and results from experimental models indicate that ALS-FUS and FTLD-FUS have distinct pathogenic mechanisms.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28096243      PMCID: PMC5710099          DOI: 10.1101/cshperspect.a024299

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  100 in total

Review 1.  Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.

Authors:  Sandrine Da Cruz; Don W Cleveland
Journal:  Curr Opin Neurobiol       Date:  2011-08-02       Impact factor: 6.627

2.  FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.

Authors:  F Mori; K Tanji; T Kon; S Odagiri; M Hattori; Y Hoshikawa; C Kono; K Yasui; S Yokoi; Y Hasegawa; M Yoshida; K Wakabayashi
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

3.  Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.

Authors:  Ian R A Mackenzie; Olaf Ansorge; Michael Strong; Juan Bilbao; Lorne Zinman; Lee-Cyn Ang; Matt Baker; Heather Stewart; Andrew Eisen; Rosa Rademakers; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2011-05-21       Impact factor: 17.088

4.  Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family.

Authors:  Adam L Boxer; Ian R Mackenzie; Bradley F Boeve; Matthew Baker; William W Seeley; Richard Crook; Howard Feldman; Ging-Yuek R Hsiung; Nicola Rutherford; Victor Laluz; Jennifer Whitwell; Dean Foti; Eric McDade; Jennifer Molano; Anna Karydas; Aleksandra Wojtas; Jill Goldman; Jacob Mirsky; Pheth Sengdy; Stephen Dearmond; Bruce L Miller; Rosa Rademakers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-20       Impact factor: 10.154

5.  FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.

Authors:  Hazel Urwin; Keith A Josephs; Jonathan D Rohrer; Ian R Mackenzie; Manuela Neumann; Astrid Authier; Harro Seelaar; John C Van Swieten; Jeremy M Brown; Peter Johannsen; Jorgen E Nielsen; Ida E Holm; Dennis W Dickson; Rosa Rademakers; Neill R Graff-Radford; Joseph E Parisi; Ronald C Petersen; Kimmo J Hatanpaa; Charles L White; Myron F Weiner; Felix Geser; Vivianna M Van Deerlin; John Q Trojanowski; Bruce L Miller; William W Seeley; Julie van der Zee; Samir Kumar-Singh; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Eileen H Bigio; Han-Xiang Deng; Glenda M Halliday; Jillian J Kril; David G Munoz; David M Mann; Stuart M Pickering-Brown; Valerie Doodeman; Gary Adamson; Shabnam Ghazi-Noori; Elizabeth M C Fisher; Janice L Holton; Tamas Revesz; Martin N Rossor; John Collinge; Simon Mead; Adrian M Isaacs
Journal:  Acta Neuropathol       Date:  2010-05-20       Impact factor: 17.088

6.  Continuum of frontal lobe impairment in amyotrophic lateral sclerosis.

Authors:  Jennifer M Murphy; Roland G Henry; Susan Langmore; Joel H Kramer; Bruce L Miller; Catherine Lomen-Hoerth
Journal:  Arch Neurol       Date:  2007-04

7.  Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.

Authors:  C Troakes; T Hortobágyi; C Vance; S Al-Sarraj; B Rogelj; C E Shaw
Journal:  Neuropathol Appl Neurobiol       Date:  2013-08       Impact factor: 8.090

8.  Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.

Authors:  Y S Davidson; A C Robinson; Q Hu; M Mishra; A Baborie; E Jaros; R H Perry; N J Cairns; A Richardson; A Gerhard; D Neary; J S Snowden; E H Bigio; D M A Mann
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

9.  A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.

Authors:  Tammaryn Lashley; Jonathan D Rohrer; Rina Bandopadhyay; Charles Fry; Zeshan Ahmed; Adrian M Isaacs; Jack H Brelstaff; Barbara Borroni; Jason D Warren; Claire Troakes; Andrew King; Safa Al-Saraj; Jia Newcombe; Niall Quinn; Karen Ostergaard; Henrik Daa Schrøder; Marie Bojsen-Møller; Hans Braendgaard; Nick C Fox; Martin N Rossor; Andrew J Lees; Janice L Holton; Tamas Revesz
Journal:  Brain       Date:  2011-07-12       Impact factor: 13.501

10.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

View more
  6 in total

Review 1.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

2.  Loss of Dynamic RNA Interaction and Aberrant Phase Separation Induced by Two Distinct Types of ALS/FTD-Linked FUS Mutations.

Authors:  Amirhossein Ghanbari Niaki; Jaya Sarkar; Xinyi Cai; Kevin Rhine; Velinda Vidaurre; Brian Guy; Miranda Hurst; Jong Chan Lee; Hye Ran Koh; Lin Guo; Charlotte M Fare; James Shorter; Sua Myong
Journal:  Mol Cell       Date:  2019-10-17       Impact factor: 17.970

Review 3.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

Review 4.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

5.  The ALS-Associated FUS (P525L) Variant Does Not Directly Interfere with Microtubule-Dependent Kinesin-1 Motility.

Authors:  Anne Seifert; Hauke Drechsler; Julia Japtok; Till Korten; Stefan Diez; Andreas Hermann
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

6.  Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.

Authors:  Laura Strohm; Zehan Hu; Yongwon Suk; Alina Rühmkorf; Erin Sternburg; Vanessa Gattringer; Henrick Riemenschneider; Riccardo Berutti; Elisabeth Graf; Jochen H Weishaupt; Monika S Brill; Angelika B Harbauer; Dorothee Dormann; Jörn Dengjel; Dieter Edbauer; Christian Behrends
Journal:  Life Sci Alliance       Date:  2022-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.